The Cost-Effectiveness of EndoPredict to Inform Adjuvant Chemotherapy Decisions in Early Breast Cancer

Hinde, Sebastian orcid.org/0000-0002-7117-4142, Theriou, Chloi, May, Shirley et al. (4 more authors) (2019) The Cost-Effectiveness of EndoPredict to Inform Adjuvant Chemotherapy Decisions in Early Breast Cancer. Health Policy and Technology. pp. 75-83. ISSN 2211-8845

Abstract

Metadata

Authors/Creators:
Copyright, Publisher and Additional Information: © Elsevier, 2018. This is an author-produced version of the published paper. Uploaded in accordance with the publisher’s self-archiving policy.
Keywords: Breast cancer, Cost-effectiveness, Economic evaluation, EndoPredict, Gene expression, Risk of recurrence
Dates:
  • Accepted: 14 December 2018
  • Published (online): 24 December 2018
  • Published: 1 March 2019
Institution: The University of York
Academic Units: The University of York > Faculty of Social Sciences (York) > Centre for Health Economics (York)
Depositing User: Pure (York)
Date Deposited: 20 Dec 2018 15:40
Last Modified: 06 Dec 2023 12:54
Published Version: https://doi.org/10.1016/j.hlpt.2018.12.001
Status: Published
Refereed: Yes
Identification Number: https://doi.org/10.1016/j.hlpt.2018.12.001
Related URLs:

Download

Filename: CE_endopredict_paper_accepted.docx

Description: CE endopredict paper accepted

Licence: CC-BY-NC-ND 2.5

Export

Statistics